{"id":"vykat-xr","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":{"chemblId":"CHEMBL258896","moleculeType":"Small molecule","molecularWeight":"549.67"},"_dailymed":{"setId":"0e745e85-9512-e360-e063-6394a90aebf1","title":"VYKAT XR (DIAZOXIDE CHOLINE) TABLET, FILM COATED [SOLENO THERAPEUTICS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"VYKAT XR uses Soleno's proprietary AQORAL technology to deliver potassium in a controlled, extended-release manner throughout the gastrointestinal tract. This approach aims to minimize gastrointestinal irritation and tolerability issues associated with conventional potassium supplements while maintaining therapeutic efficacy in correcting low serum potassium levels.","oneSentence":"VYKAT XR is a sustained-release formulation of potassium that provides controlled delivery of potassium to treat hypokalemia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:57:35.015Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypokalemia (low serum potassium)"}]},"trialDetails":[{"nctId":"NCT07450664","phase":"","title":"Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Soleno Therapeutics, Inc.","startDate":"2025-11-26","conditions":"Prader-Willi Syndrome","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20250326","type":"ORIG","sponsor":"SOLENO THERAP","applicationNumber":"NDA216665"}],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"VYKAT XR","genericName":"VYKAT XR","companyName":"Soleno Therapeutics, Inc.","companyId":"soleno-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"VYKAT XR is a sustained-release formulation of potassium that provides controlled delivery of potassium to treat hypokalemia. Used for Hypokalemia (low serum potassium).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}